Margot Mongold
Corporate Officer/Principal chez Society for Human Resources Management
Profil
Margot Mongold currently works at Society for Human Resources Management, as Member.
Ms. Mongold also formerly worked at CASI Pharmaceuticals, Inc., as Senior Director-Human Resources from 2000 to 2004, GenVec, Inc., as Head-Human Resources, and GlycoMimetics, Inc., as Vice President-Human Resources.
Ms. Mongold received her graduate degree from George Washington University and undergraduate degree from American University.
Postes actifs de Margot Mongold
| Sociétés | Poste | Début |
|---|---|---|
| Society for Human Resources Management | Corporate Officer/Principal | - |
Anciens postes connus de Margot Mongold
| Sociétés | Poste | Fin |
|---|---|---|
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Human Resources Officer | 01/01/2004 |
| GENVEC INC | Human Resources Officer | - |
| GLYCOMIMETICS, INC. | Human Resources Officer | - |
Formation de Margot Mongold
| George Washington University | Graduate Degree |
| American University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GLYCOMIMETICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
| Society for Human Resources Management |
